Further to earlier communication dated November 13, 2019, intimating about amalgamation of Zydus Technologies with the Company, Cadila Healthcare has infromed that the Board of Directors at their meeting held today, have now approved the draft Scheme of Amalgamation for amalgamation of Zydus Technologies (ZTL), Alidac Pharmaceuticals (APL), Liva Pharmaceuticals (LPL) and Dialforhealth India (DHIL) with Cadila Healthcare (CHL). ZTL, APL, LPL and DHIL are the wholly owned subsidiaries of the Company. The amalgamation is subject to the necessary approvals/ sanctions, from the National Company Law Tribunal, Bench at Ahmedabad or such other competent authority and shareholders and creditors of CHL, ZTL, APL, LPL and DHIL, if appiicable. The details as required under regulation 30 of the SEBI Regulations read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015 in the prescribed format with regard to draft scheme of amalgamation are enclosed.
The above information is a part of company’s filings submitted to BSE.
